Authors: ASCHELE C BALDO C SOBRERO AF DEBERNARDIS D BORNMANN WG BERTINO JR

Citation: C. Aschele et al., SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO, Clinical cancer research, 4(5), 1998, pp. 1323-1330

Authors: ASCHELE C BALDO C SOBRERO AF DEBERNARDIS D BORNMANN WG BERTINO JR

Citation: C. Aschele et al., SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO, Clinical cancer research, 4(5), 1998, pp. 1323-1330

Authors: ZIMMERMAN C BALDO C MOLINO A

Citation: C. Zimmerman et al., PROBABILITY OF CURE, RISK OF RECURRENCE - DOES FRAMING OF OUTCOME INFLUENCE BREAST-CANCER PATIENTS (BC PTS) CHOICE OF ADJUVANT CHEMOTHERAPY(ACT) IN HYPOTHETICAL PATIENT SCENARIOS, Breast, 6(5), 1997, pp. 321-321

Authors: MOLINO A BALDO C POLLINI GP RIGOTTI G MODENA S ZIMMERMANN C

Citation: A. Molino et al., QUALITY-OF-LIFE AND PERSONAL FEELINGS FOLLOWING QUADRANTECTOMY (Q) ORMASTECTOMY WITH RECONSTRUCTIVE SURGERY (M-CANCER PATIENTS (BCP)(R) INBREAST), European journal of cancer, 33, 1997, pp. 353-353

Authors: GUGLIELMI A ASCHELE C MORI A BALDO C RUSSO P DEBERNARDIS D VALENTI M BRUNO S TAVERNA M ROSSO R SOBRERO A

Citation: A. Guglielmi et al., IN-VITRO SYNERGISM BETWEEN 5-FLUOROURACIL AND NATURAL BETA-INTERFERONIN HUMAN COLON-CARCINOMA CELLS, Clinical cancer research, 1(11), 1995, pp. 1337-1344